PAA 8.89% 20.5¢ pharmaust limited

Ann: PharmAust makes Head of Manufacturing appointment, page-8

  1. 6,595 Posts.
    lightbulb Created with Sketch. 1653
    Agreed. Also, only a company which has belief in its drugs would put so much into it as today’s Ann shows by appointing a head of manufacturing and engaging 2 world leading manufacturing companies. Please don’t underestimate how much public and media attention is on Relyvrio’s withdrawal and the void created again for ALS patients. I think the company is striking while the iron is hot and thru a structured and controlled approach because FDA isn’t going to approve anything in a hurry in the near term as it will be a big embarrassment. So moving ahead with speed to capitalise on the tailwinds but in a systematic and scientific manner is the right thing to do. AIMO.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.020(8.89%)
Mkt cap ! $81.16M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $331.9K 1.617M

Buyers (Bids)

No. Vol. Price($)
4 440882 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 12736 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.